Artificial Intelligence assisted echocardiography to support diagnosis of heart failure: Early Value AssessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 20 May 2026
Enlicitide decanoate for treating hyperlipidaemia in people at risk of an atherosclerotic cardiovascular disease event [ID6656]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Extravascular implantable cardioverter defibrillator insertion for preventing sudden cardiac deathStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction [ID6514]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 4 June 2026
Pelacarsen for reducing the risk of cardiovascular events in people with established cardiovascular disease and high lipoprotein (a) [ID6559]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Percutaneous insertion of a catheter-based intravascular microaxial flow pump for cardiogenic shockStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 25 March 2026
Pulmonary artery pressure technologies for remote monitoring of chronic heart failure (HTG769)Product type:GuidanceProgramme:HealthTech guidancePublished: 5 February 2026
Surgical insertion of a catheter-based intravascular microaxial flow pump for cardiogenic shockStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 25 March 2026
Tirzepatide for reducing the risk of major adverse cardiovascular events in people with type 2 diabetes and cardiovascular disease [TSID12347]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC